These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22951311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers.
    Bissa M, Illiano E, Pacchioni S, Paolini F, Zanotto C, De Giuli Morghen C, Massa S, Franconi R, Radaelli A, Venuti A.
    J Transl Med; 2015 Mar 05; 13():80. PubMed ID: 25763880
    [Abstract] [Full Text] [Related]

  • 3. Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
    Illiano E, Bissa M, Paolini F, Zanotto C, De Giuli Morghen C, Franconi R, Radaelli A, Venuti A.
    Virus Res; 2016 Oct 02; 225():82-90. PubMed ID: 27664839
    [Abstract] [Full Text] [Related]

  • 4. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
    Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H.
    J Virol Methods; 2014 Sep 02; 206():12-8. PubMed ID: 24880067
    [Abstract] [Full Text] [Related]

  • 5. Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits.
    Radaelli A, Pozzi E, Pacchioni S, Zanotto C, Morghen Cde G.
    J Transl Med; 2010 Apr 21; 8():40. PubMed ID: 20409340
    [Abstract] [Full Text] [Related]

  • 6. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins.
    Pozzi E, Basavecchia V, Zanotto C, Pacchioni S, Morghen Cde G, Radaelli A.
    J Virol Methods; 2009 Jun 21; 158(1-2):184-9. PubMed ID: 19428588
    [Abstract] [Full Text] [Related]

  • 7. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct 21; 29(5):584-91. PubMed ID: 18051710
    [Abstract] [Full Text] [Related]

  • 8. A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors.
    Wick DA, Webb JR.
    Vaccine; 2011 Oct 13; 29(44):7857-66. PubMed ID: 21816200
    [Abstract] [Full Text] [Related]

  • 9. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
    Diniz MO, Cariri FA, Aps LR, Ferreira LC.
    Hum Gene Ther; 2013 Oct 13; 24(10):861-70. PubMed ID: 24007495
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.
    Int J Mol Med; 2012 Dec 13; 30(6):1335-42. PubMed ID: 23027427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH.
    Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679
    [Abstract] [Full Text] [Related]

  • 14. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.
    Vaccine; 2012 Feb 01; 30(6):1071-82. PubMed ID: 22178528
    [Abstract] [Full Text] [Related]

  • 15. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 16. The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.
    Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S.
    Scand J Immunol; 2012 Jan 17; 75(1):27-37. PubMed ID: 21916914
    [Abstract] [Full Text] [Related]

  • 17. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S, Duskova M, Mackova J, Pokorna D, Jinoch P, Smahel M.
    Oncol Rep; 2005 Feb 17; 13(2):311-7. PubMed ID: 15643517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70.
    Zhou L, Zhu T, Ye X, Yang L, Wang B, Liang X, Lu L, Tsao YP, Chen SL, Li J, Xiao X.
    Hum Gene Ther; 2010 Jan 17; 21(1):109-19. PubMed ID: 19715402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.